of progression in male patients who otherwise do not have a major burden of documented and important Background. The insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE ) gene prognostic factors for progressive renal insufficiency. determines the concentration of ACE in serum and
patients with non-diabetic, chronic progressive renal Introduction insufficiency. Seventy non-diabetic patients, aged 21-69 years at baseline, with moderately advanced Polymorphism of the angiotensin I-converting enzyme renal insufficiency due to primary chronic renal (ACE) gene was identified in 1990 [1] . The insertion/ disease were followed for an average of 3 years with deletion (I/D) polymorphism of the ACE gene has repeated measurements of their glomerular filtration been shown to determine the concentration of ACE in rate (GFR). Their mean GFR at baseline was serum and in local tissues [2, 3] . The pathophysiological 41 ml/min/1.73 m2 body surface area (BSA). The polyrole of this polymorphism has been discussed and it merase chain reaction (PCR) amplification method has been proposed that the DD genotype of the ACE was used to detect the I/D polymorphism of the ACE gene may be an independent risk factor for cardiac gene. GFR was measured as the clearance of 51Cr-disease [4] [5] [6] [7] [8] . Whether the I/D polymorphism plays EDTA and the individual rate of progression was an important role in renal disease is still controversial calculated using linear regression.
[9].
Results. The distributions of the genotypes were: D/D
In diabetic nephropathy there are conflicting results 30%, I/D 49%, and I/I 21%. The rates of progresregarding whether patients with the DD genotype sion in the three ACE genotype groups were an progress in their renal insufficiency at a higher rate annual decline in renal function of −4.2 (SD [10] [11] [12] [13] [14] . In the meta-analysis of Staessen et al.
[8] it 4.6) ml/min×1.73 m2 BSA in the D/D group, −2.7 was concluded that the deletion polymorphism sets the (SD 3.4) in the I/D group and −1.7 (SD 3.4) in the stage for renal microvascular complications. Studies in I/I group (ANOVA P=0.12). In patients with propatients with IgA nephropathy have suggested that the teinuria below 3.5 g/24 h, the D/D group had a signi-I/D polymorphism may play a role in the progression ficantly higher rate of progression than patients with of this particular renal disease [15] [16] [17] [18] [19] [20] . In three recent, the I allele. The same was found in a separate analysis but rather small, studies it was reported that the decline when only patients with normal apoliprotein B (below in renal function was also more rapid in patients with 155 mg/dl ) levels were analysed. Furthermore, the D/D the DD genotype in other non-diabetic renal patient genotype was a significant predictor of a more rapid categories [21] [22] [23] . Furthermore, it has also been decline in renal function in male, but not female, discussed whether the therapeutic response to ACEpatients.
inhibition is dependent on the ACE gene polymorphConclusion. The results in this study in non-diabetic ism [9, 15, 17, 21, 24, 25] . patients with chronic renal disease indicate that the As pointed out in two recent reviews [9, 26 ] , a presence of the D allele in the ACE genotype may be common problem in addressing the question of whether of particular importance as a predictor of a high rate gene polymorphism plays a role in various renal diseases is the limited size of the patient samples, with Correspondence and offprint requests to: O. Samuelsson, M. D., consequently low statistical power. The aim of the with an oligonucleotide for specific sequences in the polymorphism on the rate of progression in our amplified region.
prospectively followed patient series of subjects with non-diabetic renal disease.
Statistical methods

Patients and methods
Standard statistics were used to illustrate the salient features of the data. The individual rate of progression of renal insufficiency was calculated as the slope of GFR versus time
Patient population
plot ( linear regression) and was expressed as the annual change in GFR (ml/min/1.73 m2 BSA per year). Analysis of The patient population consisted of 70 adult non-diabetic variance (ANOVA) was used to describe and determine patients with primary chronic renal disease. They made up statistical inference between the three genotypes of the ACE the majority (96%) of the study population (n=73) of a gene, followed by pairwise comparisons. long-term, prospective observational study, the primary To evaluate whether the influence of the ACE genotype objective of which was to analyse the relationship between increased in importance when other factors important for lipid abnormalities and progressive renal insufficiency [27] .
progression were eliminated, patients with nephrotic range The patient population has been described in detail elsewhere proteinuria, uncontrolled blood pressure (defined as a blood [26 ] . Of the 70 patients, 43 had chronic glomerulonephritis, pressure >160 mmHg systolic or 90 mmHg diastolic) or 11 had chronic interstitial nephritis, eight had adult polycystic elevated apolipoprotein B levels (i.e. defined as a plasma kidney disease and eight had nephrosclerosis as the underconcentration >155 mg/100 ml ) were excluded from the lying chronic renal disease. In the remaining three patients analyses. These predictive factors were chosen based on our the renal disorder could not be diagnosed adequately. Fiftyprevious results in this prospective study [27] . Furthermore, four (77%) patients were male and 16 (23%) female. None to analyse whether the genotypes interacted with gender the of the patients was treated with any lipid-lowering therapy, study group was divided according to sex. immunosuppressive therapy or advised to follow any specified dietary regimen. At the start of the study, 64 (89%) of the patients were treated with antihypertensive therapy and Results 45 (63%) were receiving an ACE inhibitor. Only minor changes in the pharmacological treatment were made in very few patients during the study period.
The baseline patient characteristics are presented in The patients were followed with repeated visits and deter-Table 1. The sex distribution was the same in all three mination of the glomerular filtration rate (GFR). The time ACE genotype groups. The rate of progression of renal of follow-up ranged from 1 to 4 years with an average of 3.0 insufficiency was 2.6 times higher in the D/D group (SD 0.7) years, and the average number of GFR measure-than in the I/I group, with the I/D group having a ments was 9.5 (SD 3.6; range 4-17). Only two patients had progression rate in between. However, the difference fewer than five measurements during their follow-up (GFR between the three groups did not reach statistical was measured on four occasions in each).
significance (P=0.12, ANOVA). When patients with a substantial degree of proteinuria were excluded, the Methods DD genotype was found to have a significantly higher rate of progression than the patients with the I allele GFR was determined as the plasma or renal clearance ( significant, was observed when patients with poor
Urinary protein excretion was determined using a turbidometric method [29] . At the beginning of the study venous blood pressure control were excluded (data not given). blood samples were drawn into EDTA-containing vials and Table 3 shows the results when patients with high a 5-ml aliquot of blood was stored at −70°C.
plasma concentrations of apolipoprotein (apo) B were All the samples were then thawed and analysed after excluded, and it is clear that the D allele was associated completion of the observational study. Genomic DNA was with a higher rate of progression in patients with prepared using a standard method from isolated white blood normal plasma concentrations of apo B. cells and analysed using the polymerase chain reaction Male patients (n=54) with the D/D genotype had (PCR) . The primers used in the PCR detection of the ACE a significantly higher rate of progression than male gene I/D polymorphism were as described previously [30] .
patients with the I/D an I/I genotypes ( Table 4) , The PCR reaction was optimized for an equal amplification whereas in the smaller subgroups of female patients of the I and D alleles. This is of importance because the D allele is amplified more efficiently than the I allele, which can (n=16), the rate of decline in GFR was almost result in false DD genotypes. Briefly, 5 ml (~300 ng) of identical in the three genotype subgroups. The patients in the present study represented the recommended treatment strategies. Nine out of ten patients were on active antihypertensive drug therapy majority of the non-diabetic patients with chronic renal insufficiency who participated in our prospective study with the majority receiving an ACE-inhibitor. The distributions of the three ACE genotypes were the [27] , the primary objective of which was to explore the possible role of renal dyslipoproteinaemia [31] in same as reported in healthy control populations [7] .
Studies in both patients with diabetic nephropathy the progression of renal dysfunction. This patient group was representative of unselected adult asympto-and non-diabetic patients with other underlying renal diseases have suggested that patients with the D/D matic subjects with moderately advanced renal insufficiency due to primary renal disease with charac-genotype in the ACE gene progress at a higher rate than those with the I allele [12] [13] [14] [15] [16] [17] [18] [19] [20] 26 ] . Our findings teristic alterations in the apolipoprotein, rather than the lipid, pattern [27, 31] . All patients were monitored confirm the observation by van Essen et al. [21] in a patient series very similar to ours with primary chronic closely during follow-up and managed according to 164 (27) 138 (23) 177 ( renal disease. In their recent meta-analysis, Staessen erlipidaemia and proteinuria [33, 34] . The adverse synergistic effects of proteinuria and high blood pressure et al. [8] concluded that the D allele sets the stage for atherosclerotic and renal microvascular complications have been confirmed [33] . In addition, proteinuria and elevated apo B levels have been shown to act synerin hypertension and diabetes mellitus. However, the association between the D allele and a higher rate of gistically in promoting an accelerated rate of progression [34] . The role of proteinuria in progressive renal progression in primary chronic renal disease has not been a consistent finding in all published patient disease has been discussed extensively over the last decade. There is recent evidence that heavy protenuria series [15, 32] .
The outcome of the present study, with an associ-not only serves as a marker for extensive renal damage, but also can, in itself, cause renal damage and thereby ation between the D allele and the rate of progression of renal dysfunction in our non-diabetic patients with directly aggravate the decline in renal function [35, 36 ] .
In patients with heavy proteinuria the effect of excess primary renal disease, indicates that the ACE genotype is of prognostic importance in these patient categories. proteins filtered from glomeruli into renal tubules may be of great functional importance in initiating interFurthermore, by accounting for other factors with a documented impact on the rate of progression of renal stitial inflammation and tubular atrophy [36 ] . In this category of patients, other risk factors for progression, insufficiency [33, 34] , we observed that the presence of the D/D genotype seems to be of particular prognostic such as the D/D genotype of the ACE gene, may be of minor importance due to the overriding and importimportance in patients who would otherwise be expected to be at a rather low risk of a more rapid ant damaging effects of the protein load in the renal tubules. decline in renal function. Thus, patients with low-tomoderate degrees of urinary protein excretion, normal However, patients with low to moderate proteinuria are also heterogeneous with regard to the rate of plasma levels of apo B or with normotension had a higher rate of progression if they had the D/D genotype progression. The observation in our study, and in two recent studies in IgA nephropathy [16, 19] , that the in comparison with the I/I genotype, with patients with the I/D genotype in between. This is in accordance role of the D/D genotype as a predictor of progression seems to be particularly important in patients with low with observations by Hunley et al. [16 ] and Stratta et al. [19] in their patients with IgA nephropathy, and to moderate proteinuria, indicates that the presence or absence of the D allele may be used to better identify with observations in patients with coronary heart disease, in which the D/D genotype was reported to patients with poor renal prognosis in this group of renal patients. Most of these patients would otherwise be of particular importance as a risk factor for myocardial infarction in subjects considered to be at have been regarded as being at a rather low risk for progressive renal failure. low risk according to commonly accepted coronary risk factor criteria [4] .
Many studies of the ACE gene polymorphism in chronic renal disease do not present baseline data on As stated above, the rate of progression of renal insufficiency in chronic renal disease is influenced by both proteinuria and GFR in relation to the three various genotypes. In studies in which such data are well-established risk factors such as hypertension, hyp-available there is no difference in the degree of pro-viduals at a higher risk for progressive renal insufficiency. However, at present, we do not know which, teinuria, at a similar degree of renal insufficiency, in the three ACE genotype groups [16] [17] [18] [19] [20] [21] [22] [23] 32 ]. Thus, the or even whether, particular intervention strategies should be used to improve the prognosis of the renal D/D genotype does not seem to be directly associated with heavy proteinuria. In our study, patients with the disease in these patients. Surprisingly, intensive treatment with ACE-inhibtion does not seem to be D/D genotype even had slightly less (but nonsignificantly so) proteinuria than that observed in the particularly efficacious in these patients [10, 21, 22] .
In conclusion, in this study of non-diabetic patients I/D and I/I genotype groups. Most probably, the D/D genotype does not increase the susceptibility for renal with chronic renal disease, the presence of the D allele in the ACE genotype was associated with a higher rate disease. However, the presence of this ACE gene polymorphism may potentiate the development of fur-of progression of renal insufficiency. This seemed to be of particular importance in patients who did not ther renal damage once it has occurred [19] . The mechanism(s) by which the ACE gene polymorphism have a major burden of other important prognostic factors for progressive renal failure. contributes to an accelerated loss of renal function is yet to be clarified.
The importance of the D/D genotype as a predictor
